Pharmaceutical Formulation Comprising 2,3-dimethyl-6-(n,n-dimethylaminoethyl)-6h-indolo-(2,3-b)quinoxaline

Abstract

A pharmaceutical composition for topical administration including 2,3-dimethyl-6-(N,N-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline(B-220) or a pharmaceutically acceptable salt thereof in a pharmaceutically acceptable carrier The composition is useful for the treatment of herpes virus infections of the skin or mucous membranes in a mammal subject.


Claims
Download PDF
Document Preview
Document History
  • Publication: Oct 17, 2017
  • Application: Jul 22, 2015
    US US 201514805929 A
  • Priority: Jul 22, 2015
    US US 201514805929 A
  • Priority: Aug 7, 2013
    US US 201313984105 A
  • Priority: Feb 17, 2012
    EP EP 2012052763 W
  • Priority: Feb 18, 2011
    EP EP 11154979 A
  • Priority: Feb 18, 2011
    US US 201161444275 P

Sign in to the Lens

Feedback